A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation
Abstract Ankylosing spondylitis (AS) is a common rheumatic disorder distinguished by chronic inflammation and heterotopic ossification at local entheses sites. Currently available medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs) an...
Main Authors: | Guan Zheng, Xiaoshuai Peng, Yunhui Zhang, Peng Wang, Zhongyu Xie, Jinteng Li, Wenjie Liu, Guiwen Ye, Yucong Lin, Guojian Li, Huatao Liu, Chenying Zeng, Lihua Li, Yanfeng Wu, Huiyong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-01906-2 |
Similar Items
-
Investigating the genetics and immunopathogenesis of ankylosing spondylitis
by: Liu, F
Published: (2024) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01) -
OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01) -
Prevalence of fibromyalgia in patients with ankylosing spondylitis
by: Aref Hosseinian Amiri, et al.
Published: (2014-01-01) -
EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)